THE APEX TIMES
Trading flow data cited by Yahoo Finance indicates exchange-traded funds were net sellers of Berkshire Hathaway Class B shares (BRK.B) during the Nov. 18 session, with more buyers than sellers by count but heavier selling value.
Berkshire Hathaway Class B shares (BRK.B) saw net selling by exchange-traded funds (ETFs) on Nov. 18, according to flow figures reported by Yahoo Finance. The outlet said ETFs sold a net $199.1 million worth of Berkshire Hathaway in that day’s activity, pointing to a shift in institutional positioning rather than a company-specific announcement.
The same data set showed 26 buying transactions and 17 selling transactions for Berkshire Hathaway during the session. While the number of buying accounts exceeded selling accounts, the net result was still negative, suggesting the sell orders were, on balance, larger in dollar terms.
For investors, the key point is that ETF trading can move demand for a single stock even when the underlying businesses have not changed. ETFs typically hold baskets of securities and may buy or sell components as investor fund flows change, as index constituents are rebalanced, or as trading desks execute hedges tied to the ETF’s structure.
Berkshire Hathaway does not typically disclose day-by-day changes in ETF ownership or trading flows, and Yahoo’s report does not identify which specific ETF products were responsible for the $199.1 million net selling. It also does not break down whether the selling was driven by routine rebalancing, creation and redemption activity, or portfolio hedging.
In recent years, Berkshire Hathaway has remained a widely held stock through both traditional index products and active strategies, meaning it can be pulled into the crosscurrents of broader market flows. When money moves into or out of equity ETFs, the required trades can translate into measurable buy or sell pressure on large constituents like BRK.B.
Sector context matters because ETF flow dynamics often reflect macro expectations, risk appetite, and near-term positioning. Even in a stable operating environment, large-cap holdings can face volatility when investors rebalance exposure across sectors, market capitalizations, or risk profiles. In that setting, flow-driven selling can temporarily compete with long-term demand from stock pickers.
The disclosed figures are limited to net activity on Nov. 18 and the count of buying versus selling transactions. They do not provide the duration of the selling trend beyond that date, nor do they indicate whether the net selling was concentrated in a small number of large funds or spread across many vehicles.
A market-focused note argues the company’s cash-return profile could matter as Wall Street debates whether 2027 can resemble 2022. The company, however, did not provide new disclosure in the cited post.
A market report said the U.S. Securities and Exchange Commission has opened an investigation involving Nvidia as the chipmaker absorbs fallout from a sharp selloff. Investors now have to parse what the agency is looking at and how much the matter could weigh on disclosures and governance.
A reported Phase 3 win for Moderna’s personalized melanoma therapy, used alongside Merck’s Keytruda, is prompting fresh optimism that the mRNA platform can expand beyond infectious disease. Still, key details such as magnitude of benefit and full trial disclosure remain to be validated.
Marques Brownlee said he has placed an order for Tesla’s Cybercab following a 2024 challenge, and Tesla CEO Elon Musk replied “fair enough,” saying he would accept delivery.
A new market read on Booz Allen Hamilton Holding points to a sizable gap between the company’s valuation and the cash flow the business can generate, sharpening questions for investors about how durable profits and cash generation are in the defense IT services market.
The company is pursuing Australian National Immunisation Program listings for its mRNA influenza vaccines after securing a March 2027 agenda spot with the PBAC, a key committee that advises public reimbursement.
A newly announced partnership between Microsoft and Danaher aims to pair AI-assisted capabilities with cloud-based scientific instruments and lab software, including early tools that are already moving toward commercial use.
A new market round-up from Yahoo Finance highlights how lingering discussion among Fed officials about whether interest rates need to rise again can reshape expectations for large, consumer-facing companies like PepsiCo.
The initiative, launched within Aetna, is designed to link a large share of expectant members and their newborns to coordinated maternal and infant care. CVS Health has not, in the reporting, disclosed staffing, clinical protocols, or outcome targets tied to the program.
A fresh round of holiday changes at Target centers on shopping hours and promotions, a shift the company is indicating as part of how it intends to drive demand into the end of the year.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...